NCT03043586View on ClinicalTrials.gov

Treatment Patterns and Treatment Outcomes for Acromegaly

CompletedOBSERVATIONAL
Enrollment

520

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

April 30, 2025

Study Completion Date

April 30, 2025

Conditions
Acromegaly
Trial Locations (1)

10032

Neuroendocrine Unit at Columbia University Irving Medical Center, New York

Sponsors

Collaborators (1)

Ipsen
All Listed Sponsors
collaborator

Ipsen

INDUSTRY

lead

Columbia University

OTHER